References
- Abu-Shaheen A, Heena H, Nofal A, et al. Epidemiology of thalassemia in Gulf Cooperation Council Countries: a systematic review. Biomed Res Int. 2020;2020:1509501.
- Galanello R, Origa R. β-thalassemia. Orphanet J Rare Dis. 2010;5:11.
- Weatherall DJ, Williams TN, Allen SJ, et al. The population genetics and dynamics of the thalassemias. Hematol Oncol Clin North Am. 2010;24(6):1021–1031.
- Kattamis A, Forni GL, Aydinok Y, et al. Changing patterns in the epidemiology of β-thalassemia. Eur J Haematol. 2020;105(6):692–703.
- Lee J-S, Cho SI, Park SS, et al. Molecular basis and diagnosis of thalassemia. Blood Res. 2021;56(S1):S39–S43.
- Bajwa H, Basit H. Thalassemia [Internet]. Treasure Island (FL): StatPearls; 2022 Jan [accessed 2022 Aug 8]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK531481/
- Needs T, Gonzalez-Mosquera LF, Lynch DT. β thalassemia [Internet]. Treasure Island (FL): StatPearls; 2022 Jan. Available from: https://www.ncbi.nlm.nih.gov/books/NBK531481/
- Sarnaik SA. Thalassemia and related hemoglobinopathies. Indian J Pediatr. 2005;72(4):319–324.
- Bilenoglu O, Basak AN, Russell JE. A 3'UTR mutation affects β-globin expression without altering the stability of its fully processed mRNA. Br J Haematol. 2002;119(4):1106–1114.
- Reamon-Buettner SM, Cho S-H, Borlak J. Mutations in the 3'-untranslated region of GATA4 as molecular hotspots for congenital heart disease (CHD). BMC Med Genet. 2007;8(1):38.
- Nasiri H, Forouzandeh M, Rasaee MJ, et al. Modified salting-out method: high-yield, high-quality genomic DNA extraction from whole blood using laundry detergent. J Clin Lab Anal. 2005;19(6):229–232.
- Chong SS, Boehm CD, Higgs DR, et al. Single-tube multiplex-PCR screen for common deletional determinants of α-thalassemia. Blood. 2000;95(1):360–362.
- Schwarz JM, Cooper DN, Schuelke M, et al. MutationTaster2: mutation prediction for the deep-sequencing age. Nat Methods. 2014;11(4):361–362.
- Schwarz JM, Rödelsperger C, Schuelke M, et al. MutationTaster evaluates disease-causing potential of sequence alterations. Nat Methods. 2010;7(8):575–576.
- Mahmood K, Jung C-H, Philip G, et al. Variant effect prediction tools assessed using independent, functional assay-based datasets: implications for discovery and diagnostics. Hum Genomics. 2017;11(1):10.
- Kumar P, Nagarajan A, Uchil PD. Calcium phosphate-mediated transfection of adherent cells or cells growing in suspension: variations on the basic method. Cold Spring Harb Protoc. 2019; 2019(10):pdb.prot095455.
- Haghi M, Khorshidi S, Hosseinpour Feizi MA, et al. β-Thalassemia mutations in the Iranian Kurdish population of Kurdistan and West Azerbaijan provinces. Hemoglobin. 2009;33(2):109–114.
- Moradi K, Aznab M, Biglari M, et al. Molecular genetic analysis of α-thalassemia in Hamadan Province, West Iran. Hemoglobin. 2020;44(5):319–324.
- Asadov CD, Abdulalimov ER, Mammadova TA, et al. Identification of two rare β-globin gene mutations in a patient with β-thalassemia intermedia from Azerbaijan. Hemoglobin. 2013;37(3):291–296.
- Jiang F, Mao A-P, Liu Y-Y, et al. Detection of rare thalassemia mutations using long-read single-molecule real-time sequencing. Gene. 2022;825:146438.
- Peng C, Zhang H, Ren J, et al. Analysis of rare thalassemia genetic variants based on third-generation sequencing. Sci Rep. 2022;12(1):9907.
- Oner R, Oner C, Birben E, et al. β-thalassaemia intermedia in a Turkish girl: homozygosity for G–>A substitution at +22 relative to the β-globin cap site. Br J Haematol. 2001;115(1):90–94.
- Vinciguerra M, Passarello C, Cassarà F, et al. Co-heredity of silent CAP + 1570 T > C (HBB:c*96T > C) defect and severe β-thal mutation: a cause of mild β-thalassemia intermedia. Int J Lab Hematol. 2016;38(1):17–26.
- Zhou P, Xu W, Peng X, et al. Large-scale screens of miRNA-mRNA interactions unveiled that the 3'UTR of a gene is targeted by multiple miRNAs. PLoS One. 2013;8(7):e68204.
- Krol J, Loedige I, Filipowicz W. The widespread regulation of microRNA biogenesis, function and decay. Nat Rev Genet. 2010;11(9):597–610.
- Baltz AG, Munschauer M, Schwanhäusser B, et al. The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. Mol Cell. 2012;46(5):674–690.
- Lianoglou S, Garg V, Yang JL, et al. Ubiquitously transcribed genes use alternative polyadenylation to achieve tissue-specific expression. Genes Dev. 2013;27(21):2380–2396.
- Arpaci A, Gul BU, Ozcan O, et al. Presentation of two new mutations in the 3'untranslated region of the β-globin gene and evaluating the molecular spectrum of thalassemia mutations in the Mediterranean region of Turkey. Ann Hematol. 2021;100(6):1429–1438.
- Forouzesh Pour F, Karimi K, Ghaderi Z, et al. Heterozygosity for the novel HBA2: c.*91_*92delTA polyadenylation site variant α2-globin gene expanding the genetic spectrum of α-thalassemia in Iran. Hemoglobin. 2020;44(6):423–426.
- Başak AN, Ozer A, Kirdar B, et al. A novel 13 bp deletion in the 3'UTR of the β-globin gene causes β-thalassemia in a Turkish patient. Hemoglobin. 1993;17(6):551–555.
- Bilgen T, Clark OA, Ozturk Z, et al. Two novel mutations in the 3' untranslated region of the β-globin gene that are associated with the mild phenotype of β thalassemia. Int J Lab Hematol. 2013;35(1):26–30.
- Hino M, Ito H, Yamashiro Y, et al. The +1,506 (A > C) mutation in the 3' untranslated region affects β-globin expression. Hemoglobin. 2012;36(4):399–406.
- Bonsi L, Grossi A, Strippoli P, et al. An erythroid and megakaryocytic common precursor cell line (B1647) expressing both c-mpl and erythropoietin receptor (Epo-R) proliferates and modifies globin chain synthesis in response to megakaryocyte growth and development factor (MGDF) but not to erythropoietin (Epo). Br J Haematol. 1997;98(3):549–559.